Chatterjee Mitali

Chatterjee is a Professor of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata, India. Upon completing her MBBS and MD from University of Calcutta, she received her PhD from Jadavpur University, Kolkata, India. Her work as a medical immunopharmacologist includes multiple aspects of Leishmania biology that includes (i) delineating the immunopathology of Post Kala-azar Dermal Leishmaniasis (PKDL), a disease unique to South Asia, and especially challenging as it has no animal model; (ii) development of diagnostic/prognostic objective molecular tools for monitoring anti-leishmanial therapy; and (iii) studying redox-dysfunction as an effective leishmanicidal approach. In sum, the thrust of Chatterjee’s work is translational research in Indian Leishmaniasis with a view towards facilitating a greater understanding of disease pathogenesis through worldwide collaborations across geographic borders, and supporting the ongoing kala-azar elimination programme. She is a member of four Indian science academies and has over 175 publications in leading International journals (Clin Infect Dis, J Invest Dermatol, J Clin Invest, J Inf Dis).